Endocrinology: from the daily briefing

Every daily briefing item tagged endocrinology, newest first. The weekly roundup is on the endocrinology page.

• Oct 29, 2026Lilly's retatrutide beats Ozempic head to head in type 2 diabetes, with about 21% weight loss vs. 9% at 80 weeksShareEvidence
• Oct 29, 2026Ascletis oral GLP-1 candidate meets primary and secondary endpoints in phase 2 diabetes trialEvidence
• Oct 29, 2026Analysis finds compounded GLP-1 drugs widely coformulated with vitamin B12 and other additives FDA never evaluatedEvidence
• Oct 28, 2026Acmopatide reduces weight 3.3% to 6.7% over 16 weeks in adults with type 1 diabetes and overweightEvidence
• Oct 27, 2026SGLT2 inhibitors linked to less acute kidney injury and hospitalization than DPP-4 inhibitors in adults 75 and olderEvidence
• Oct 27, 2026Semaglutide linked to lower mortality than dulaglutide or liraglutide in patients on hemodialysisEvidence
• Oct 26, 2026Retatrutide reduces apnea-hypopnea index in obstructive sleep apnea with obesity in phase 3 trialsEvidence
• Oct 22, 2026Medtronic recalls MiniMed Go app after long-acting dose reminder fails for some usersIncident
• Oct 19, 2026FDA clears Sequel's twiist automated insulin delivery system for adults with insulin-treated type 2 diabetesShareRegulation
• Oct 16, 2026Continuous glucose monitors cut A1C 0.9 point more than routine care in type 2 diabetes without insulin, Dexcom-funded NEJM trial findsShareEvidence
• Oct 13, 2026Google's $179.99 Fitbit Edge adds AI blood pressure and insulin resistance trend alerts, labeled for general wellness onlyShareDeployment
• Oct 10, 2026Chest X-ray model identifies osteoporosis with AUROCs of 0.88 to 0.93 in three Korean validation cohorts of more than 150,000 examsShareEvidence